Cancer drug-tolerant persister cells: from biological questions to clinical opportunities. (2024)

First Author: Russo M
Attributed to:  Targeting developmental cell states in melanoma funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41568-024-00737-z

PubMed Identifier: 39223250

Publication URI: http://europepmc.org/abstract/MED/39223250

Type: Journal Article/Review

Volume: 24

Parent Publication: Nature reviews. Cancer

Issue: 10

ISSN: 1474-175X